To celebrate the decade that has passed since the landmark discovery of induced pluripotent stem cells, Cell Press hosted “10 Years of iPSCs,” a symposium focused on iPSC research and applications. In 2006, Shinya Yamanaka and Kazutoshi Takahashi reported the Nobel Prize winning discovery of induced pluripotent stem cells (iPSCs) in Cell.
Over the past 10 years, iPS cells have become a lab workhorse — providing an unlimited supply of once-inaccessible human tissues with specific genetic mutations for research.
iPSC technology also spurred renewed interest in direct reprogramming across lineages. Progress in understanding the biology of iPSCs and reprogramming has moved in parallel with work on clinical translation to apply the insights obtained, and the first iPSC-based clinical trials are now underway within Japan and launching within the UK.
About “10 Years of iPSCs” by Cell Press
Cell Press is excited to bring together leaders in biology, medicine, and industry to give an up-to-date view of this exciting and rapidly moving area. At this meeting, you can expect to hear about the latest advances in technology development, mechanistic understanding, and therapeutic application of reprogramming for both drug development and cell-based therapy.
The goal of the meeting is to serve as a catalyst for new ideas and future growth as the iPSC and reprogramming field enters its second decade.
Key themes will include:
-
- Mechanisms of reprogramming
- Disease modeling and drug discovery
- Direct reprogramming
- Technology development
- Clinical translation
There will also be a panel on ethical considerations for clinical translation of iPSC research, on Sunday, September 25, 2016, from 17:00-18:00.
Symposium speakers Shinya Yamanaka, George Daley, Christine Mummery, Lorenz Studer, and Deepak Srivastava, and Bioethicist Hank Greely will discuss the most pressing ethics issues facing the field as it moves towards the clinic. Discussion topics will range from the ethics of patient and donor consent in iPSC banking and application to medical use of genome-edited iPSC derivatives and lessons from existing approaches in gene and cell therapy.
Speakers at “10 Years of iPSCs” Symposium
The keynote speakers for the “10 Years of iPSCs” are Shinya Yamanaka (Japan/USA) and Rudolf Jaenisch (USA).
Other speakers for the conference include:
- Kristin Baldwin, USA
- Juan Carlos Izpisua Belmonte, USA
- Nissim Benvenisty, Israel
- George Daley, USA
- Hongkui Deng, China
- Sheng Ding, USA
- Kevin Eggan, USA
- Sandra Engle, USA
- Koji Eto, Japan
- Magdalena Götz, Germany
- Henry T. (Hank) Greely, USA
- Guo-li Ming, USA
- Christine Mummery, The Netherlands
- Kathrin Plath, USA
- Hans Schöler, Germany
- Deepak Srivastava, USA
- Lorenz Studer, USA
- Kazutoshi Takahashi, Japan/USA
- Marius Wernig, USA
Conference Dates and Location
The conference is being held on September 25-27, 2016, in Berkeley, California.
To learn more about the event, visit: http://www.cell-symposia-ipscs.com